Sign in

SNYRQ on OTC

Synergy CHC Corp.

Synergy CHC Corp. is an American medicinal chemicals and botanical products company.1 It is headquartered in Westbrook, Maine.1 Its shares trade on OTC under the symbol SNYRQ.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with C21 Investments Inc., Leef Brands Inc. or CYANOTECH CORP, or pick any stock.

  • TickerSNYRQ on OTC1
  • IndustryMedicinal Chemicals & Botanical Products1
  • HeadquartersWestbrook, Maine1
  • Incorporated inNV2
  • Business address865 Spring Street, Westbrook, Me 040922
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Website: Our FOCUSfactor website helps to educate and inform consumers on our line of products. The website also serves as a direct-to-consumer sales channel for most FOCUSfactor products.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

66.8%Gross margin5
-27.8%Operating margin5
-40.6%Net margin5
-12.8%Revenue growth, 20255

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Retail brought in 67% of the revenue Synergy CHC Corp. broke down this way in fiscal 2025.

  1. Retail$22.2M567%down 16% from 2024
  2. Online$8.1M524%down 3% from 2024
  3. License Revenue$2.9M59%
Products and services by year
Products and services20242025
Retail$26.5M$22.2M
Online$8.4M$8.1M
License Revenue$2.9M

Business segments

Nutraceuticals brought in 98% of the revenue Synergy CHC Corp. broke down this way in fiscal 2025.

  1. Nutraceuticals$29.7M598%down 11% from 2024
  2. Beverages$631.3K52%down 56% from 2024
  3. Consumer goods$18.0K50%up 6% from 2024
Business segments by year
Business segments20242025
Nutraceuticals$33.4M$29.7M
Beverages$1.4M$631.3K
Consumer goods$16.9K$18.0K

Regions

United States brought in 90% of the revenue Synergy CHC Corp. broke down this way in fiscal 2025.

  1. United States$27.3M590%down 11% from 2024
  2. Canada$2.4M58%down 38% from 2024
  3. M X$623.7K52%up 17043% from 2024
  4. Other$20.7K50%down 72% from 2024
Regions by year
Regions20242025
United States$30.8M$27.3M
Canada$3.9M$2.4M
M X$3.6K$623.7K
Other$73.0K$20.7K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue33¢$10.1M
  • Other costs66¢$20.2M
  • Income tax0¢$117.5K

Out of $30.4M in revenue.5 The company lost money this year.

Financial statements

Revenue675$30.4M in 2025−10% since 2018
0$20.0M$40.0M$60.0M2018: $33.8M$33.8M20182019: $29.4M$29.4M2019−13%2023: $42.8M$42.8M2023+46%2024: $34.8M$34.8M2024−19%2025: $30.4M$30.4M2025−13%
Gross profit675$20.3M in 2025−11% since 2018
0$10.0M$20.0M$30.0M$40.0M2018: $22.8M$22.8M20182019: $20.2M$20.2M2019−11%2023: $32.1M$32.1M2023+59%2024: $23.6M$23.6M2024−26%2025: $20.3M$20.3M2025−14%
Operating income675-$8.5M in 2025+72% since 2018
-$10.0M-$5.0M0$5.0M$10.0M$15.0M2018: -$4.9M-$4.9M20182019: -$8.0M-$8.0M2019+62%2023: $10.8M$10.8M20232024: $5.8M$5.8M2024−46%2025: -$8.5M-$8.5M2025
Net income675-$12.3M in 2025+100% since 2018
-$15.0M-$10.0M-$5.0M0$5.0M$10.0M2018: -$6.2M-$6.2M20182019: -$9.2M-$9.2M2019+49%2023: $6.3M$6.3M20232024: $2.1M$2.1M2024−66%2025: -$12.3M-$12.3M2025

Every line of the income statement as filed: the last 2 fiscal years, latest first.5

Period ending2025-12-312024-12-31
Revenue$30.4M$34.8M
Cost of sales$10.1M$11.2M
Gross Profit$20.3M$23.6M
Selling and marketing$13.1M$13.0M
General and administrative$8.8M$4.7M
Reserve for bad debts$6.7M
Depreciation and amortization$133.3K$133.3K
Total operating expenses$28.8M$17.8M
(Loss) Income from operations-$8.5M$5.8M
Other income-$510.5K
Interest income-$15.1K-$1.5K
Interest expense$5.9M$4.1M
Gain on settlement of notes payable-$2.2M
Remeasurement loss (gain) on translation of foreign subsidiary$14.8K-$19.0K
Total other expenses$3.8M$3.6M
Net (loss) income before income taxes-$12.2M$2.2M
Income tax expense$117.5K$102.1K
Net (loss) income-$12.3M$2.1M
Net (loss) income per share basic (in Dollars per share)-$1.27$0.28
Net (loss) income per share - diluted (in Dollars per share)-$1.27$0.28
Basic (in Shares)9.7M shares7.6M shares
Diluted (in Shares)9.7M shares7.6M shares
Foreign currency translation adjustment-$106.5K$54.7K
Comprehensive (loss) income-$12.4M$2.2M

Compare Synergy CHC Corp. with another company

Corporate structure

Synergy CHC Corp. sits at the top of its group. 4 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Synergy CHC Corp.

  • Knight Therapeutics Filed SCHEDULE 13G/A on Synergy CHC Corp., latest Jun 13, 2025 (2 filings since Mar 20, 2025)
  • Jack Ross Filed SC 13D on Synergy CHC Corp., latest Oct 31, 2024
  • SANDERS MORRIS HARRIS LLC Filed SC 13G on Synergy CHC Corp., latest Oct 25, 2024
  • Synergy CHC Corp. Westbrook, Maine
    • Hand MD Corp. Subsidiary · Delaware, United States
    • NomadChoice Pty Ltd. Subsidiary · Australia
    • Synergy CHC Mexico Subsidiary · Mexico

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Synergy CHC Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$2.6M5 Dec 31, 2025$687.9K5 Dec 31, 2024+281.2%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$150.0K5 Dec 31, 2025$283.3K5 Dec 31, 2024−47.1%
Finite-lived intangibles, gross$450.0K5 Dec 31, 2025$450.0K5 Dec 31, 20240%
Accumulated amortization$300.0K5 Dec 31, 2025$166.7K5 Dec 31, 2024+80.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$3.7M5 Dec 31, 2025$1.7M5 Dec 31, 2024+117.7%
Raw materials$45.0K5 Dec 31, 2024$45.0K7 Dec 31, 20230%
Work in process$412.4K5 Dec 31, 2025$93.0K5 Dec 31, 2024+343.5%
Finished goods$3.3M5 Dec 31, 2025$1.6M5 Dec 31, 2024+110.6%

Properties, in its own words

The following table describes our principal properties leased as of the date of this Annual Report.

Purpose · Location · Square Footage

The rest of Item 2

Office(1) · Halifax, NS · 8,500

(1) · Monthly rental payments are $19,608 Canadian Dollars per month on a month-to-month basis.

Item 2 of the 10-K filed Apr 1, 2026.4

Leadership

Who has led Synergy CHC Corp., and when. Pick a name to see everywhere that person has worked.

President

  1. Patrick S. McCullough2017
  2. Alfred Baumeler2024–now

Chief financial officer

  1. Jeffrey Kadanoff2017
  2. Stacy B. McLaughlin2024
  3. Jaime Fickett2025–now
20202025
Board members and other officers (8)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Hand MD Corp. Delaware3
  • NomadChoice Pty Ltd. Australia3
  • Synergy CHC Inc. Canada3
  • Synergy CHC Mexico Mexico3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • Synergy Strips Corp.May 7, 2014 to Aug 6, 20152
  • Oro Capital Corporation, Inc.Nov 21, 2012 to Apr 24, 20142

Timeline

  1. Sep 16, 20268-K Listing notice or transfer23
  2. Sep 8, 20268-K Bankruptcy or receivership; Executive or director change24
  3. Aug 26, 20268-K Debt or obligation accelerated25
  4. Aug 21, 20268-K Listing notice or transfer; Regulation FD disclosure26
  5. Aug 11, 20268-K Debt or obligation accelerated27
  6. Jul 29, 20268-K Other events28
  7. Jun 29, 20268-K Executive or director change; Shareholder vote29
  8. May 18, 20268-K Listing notice or transfer30
  9. May 14, 20268-K Results of operations31
  10. May 11, 20268-K Entered a material agreement32
  11. Mar 25, 20268-K Entered a material agreement; New debt or obligation; Unregistered sale of shares33
  12. Mar 3, 20268-K Other events34

Calendar

When it reported results

  1. May 14, 2026Reported quarterly or annual results31
  2. Nov 13, 2025Reported quarterly or annual results35
  3. Aug 14, 2025Reported quarterly or annual results36
  4. May 15, 2025Reported quarterly or annual results37
  5. Mar 31, 2025Reported quarterly or annual results38
  6. Dec 6, 2024Reported quarterly or annual results39

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

123 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 25 major events, 25 insider forms, 4 large holders, 62 other. The latest 20:

  1. Sep 16, 20268-K CURRENT REPORT EDGAR
  2. Sep 8, 20268-K CURRENT REPORT EDGAR
  3. Aug 26, 20268-K CURRENT REPORT EDGAR
  4. Aug 21, 20268-K CURRENT REPORT EDGAR
  5. Aug 11, 20268-K CURRENT REPORT EDGAR
  6. Jul 29, 20268-K CURRENT REPORT EDGAR
  7. Jul 1, 20264 PRIMARY DOCUMENT EDGAR
  8. Jul 1, 20264 PRIMARY DOCUMENT EDGAR
  9. Jul 1, 20264 PRIMARY DOCUMENT EDGAR
  10. Jun 29, 20268-K CURRENT REPORT EDGAR
  11. May 22, 2026EFFECT EDGAR
  12. May 21, 2026CORRESP EDGAR
  13. May 21, 2026UPLOAD EDGAR
  14. May 18, 20268-K CURRENT REPORT EDGAR
  15. May 15, 2026S-1 REGISTRATION STATEMENT EDGAR
  16. May 14, 20268-K CURRENT REPORT EDGAR
  17. May 14, 202610-Q QUARTERLY REPORT EDGAR
  18. May 11, 20268-K CURRENT REPORT EDGAR
  19. Apr 30, 2026ARS ANNUAL REPORT EDGAR
  20. Apr 30, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS EDGAR

The 123 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

123 open-market trades by officers, directors and large owners since October 2021: 123 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jul 30, 2025Ross JackCEO and ChairmanBuy100$3.69$369Form 4
Jul 29, 2025Ross JackCEO and ChairmanBuy250$3.66$915Form 4
Jul 25, 2025Ross JackCEO and ChairmanBuy350$3.90$1.4KForm 4
Jul 24, 2025Ross JackCEO and ChairmanBuy300$3.83$1.1KForm 4
Jul 22, 2025Ross JackCEO and ChairmanBuy300$3.54$1.1KForm 4
Jul 11, 2025Ross JackCEO and ChairmanBuy750$3.20$2.4KForm 4
Jul 10, 2025Ross JackCEO and ChairmanBuy1,400$3.19$4.5KForm 4
Jul 9, 2025Ross JackCEO and ChairmanBuy400$3.15$1.3KForm 4
Jul 8, 2025Ross JackCEO and ChairmanBuy800$3.36$2.7KForm 4
Jul 7, 2025Ross JackCEO and ChairmanBuy700$3.26$2.3KForm 4
Jul 3, 2025Ross JackCEO and ChairmanBuy1,750$3.22$5.6KForm 4
Jul 2, 2025Ross JackCEO and ChairmanBuy3,750$3.23$12.1KForm 4
Jul 1, 2025Ross JackCEO and ChairmanBuy250$3.05$762Form 4
Jun 30, 2025Ross JackCEO and ChairmanBuy2,600$2.69$7.0KForm 4
Jun 27, 2025Ross JackCEO and ChairmanBuy100$2.60$260Form 4
Jun 26, 2025Ross JackCEO and ChairmanBuy650$2.55$1.7KForm 4
Jun 24, 2025Ross JackCEO and ChairmanBuy600$2.63$1.6KForm 4
Jun 23, 2025Ross JackCEO and ChairmanBuy400$2.61$1.0KForm 4
Jun 20, 2025Ross JackCEO and ChairmanBuy10,300$2.60$26.8KForm 4
Jun 18, 2025Ross JackCEO and ChairmanBuy600$2.23$1.3KForm 4

All 123 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Jack Ross60$995.0K$1.1M43
2025Alfred Baumeler61$350.0K$395.4K43
2025Jaime Fickett47$379.5K$393.8K43
2024President$350.0K$398.7K43
2024Chief Financial Officer$379.5K$393.2K43
2024Chief Executive Officer and Chairman$1.3K$1.3K43

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Jane Street Group, LLC181,648$36.1K0.0%New
ACT Advisors, LLC.151,840$30.1K0.0%New
XTX Topco Ltd61,270$12.2K0.0%New
Vanguard Capital Management LLC38,909$7.7K0.0%−50,861
Geode Capital Management, LLC32,775$6.5K0.0%+11,377
Vanguard Fiduciary Trust Co16,008$3.2K0.0%−7,141
StoneX Group Inc.15,109$3.0K0.0%New
Ewa, LLC13,727$2.7K0.0%New
Citadel Advisors LLC10,902$2.2K0.0%New
Williams & Novak, LLC10,020$2.0K0.0%−1,925
Tower Research Capital LLC (TRC)3,714$7370.0%+822
Barclays PLC884$1750.0%New
Hrt Financial LP34,035$60.0%New
Virtu Financial LLC18,539$40.0%New

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Synergy CHC Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARSynergy CHC Corp.1
  • CIK0001562733
  • Employer ID (EIN)99-03794404
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company4
  • Incorporated inNevada4
  • Fiscal year endsDecember 311
  • Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address865 Spring Street, Westbrook, ME 040921
  • Phone615-939-90041
  • Shares outstanding14,899,883 as of May 11, 202610
  • Public float$13.0M as of Jun 30, 20254
  • AuditorRBSM LLP, Houston, Texas PCAOB ID 587; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceNov 21, 20121
  • Filings252 in all: 8-K (52), 10-Q (26), 4 (25), CORRESP (21), UPLOAD (18), 3 (17), S-1/A (15), 10-K (9)1
    All 42 form types

    8-K/A (7), SC 13D/A (7), EFFECT (5), S-1 (5), SC 13D (4), 4/A (3), DEF 14A (3), PRE 14A (3), 10-Q/A (2), 424B4 (2), ARS (2), DEFA14A (2), DRS (2), SC 13G (2), 10-K/A (1), 15-12G (1), 3/A (1), 424B5 (1), 8-A12B (1), 8-A12G (1), CERT (1), D (1), DEF 14C (1), DRS/A (1), DRSLTR (1), NT 10-K (1), NT 10-Q (1), PRE 14C (1), RW (1), S-1MEF (1), S-3 (1), S-8 (1), SCHEDULE 13G (1), SCHEDULE 13G/A (1)

  • Latest filingsAnnual report (10-K) Apr 1, 2026
    Quarterly report (10-Q) May 14, 2026
    Proxy statement (DEF 14A) Apr 30, 2026
    Latest 8-K (8-K) Sep 16, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, par value $0.00001 per shareSNYRNasdaq

From the cover page of the 10-K filed Apr 1, 2026 (Section 12(b) of the Exchange Act).4

Risk factors and legal proceedings

The risks Synergy CHC Corp. names in Item 1A of its 10-K filed Apr 1, 2026: 40 risks under these headings, as written.4

  • Risks Related to Our Business, Strategy and Industry
  • We operate in a highly competitive industry and our failure to compete effectively could materially and adversely affect our sales and growth prospects.
  • Our failure to appropriately respond to changing consumer preferences and demand for new products or product enhancements could significantly harm our relationship with customers and our product sales, as well as our financial condition, operating results and cash flows.
  • We depend on a small number of large retailers for a significant portion of our sales. Our sales growth is dependent upon maintaining our relationships with existing customers, and the loss of any one such customer could materially adversely affect our business and financial performance.
  • If our outside suppliers and manufacturers fail to supply products in sufficient quantities and in a timely fashion, our business could suffer.
  • While our exposure to international markets and foreign sourcing is limited, we may still be indirectly affected by global trade developments.
  • A downturn in the economy could affect consumer purchases of discretionary items such as the health and wellness products that we offer, which could have an adverse effect on our business, financial condition, profitability, and cash flows.
  • Adverse or negative publicity could cause our business to suffer.
  • We continue to explore new strategic initiatives, but we may not be able to successfully execute on, or realize the expected benefits from, the implementation of our strategic initiatives, and our pursuit of new strategic initiatives may pose significant costs and risks.
  • Current and future acquisitions may use significant resources, may be unsuccessful, and could expose us to unforeseen liabilities.
  • If we are not able to adequately prevent disclosure of proprietary knowledge, the value of our products could be materially diminished.
  • International expansion will subject our business to additional economic and operational risks that could increase our costs and make it difficult to operate profitably.
The other 29 risks
  • We may experience product recalls, withdrawals or seizures, which could materially and adversely affect our business, financial condition, results of operations and cash flows.
  • Increases in the price or shortages of supply of key raw materials could materially and adversely affect our business, financial condition, results of operations and cash flows.
  • We are subject to credit risk.
  • Natural disasters and unusually adverse weather conditions could cause permanent or temporary damage to our distribution centers, impair our ability to purchase, receive or replenish inventory or cause customer traffic to decline, all of which could result in lost sales and otherwise materially and adversely affect our results of operations and cash flows.
  • Loss of key vendor relationships or failure of a vendor to protect our data or confidential and proprietary information could affect our operations.
  • Our e-commerce business is dependent on certain third parties. Changes in business practices or terms by such third parties could have a material adverse effect on our results of operations.
  • If we do not successfully develop and maintain a relevant omni-channel experience for our customers, our business and results of operations could be materially and adversely affected.
  • Our officers and directors have the ability to significantly influence or control matters requiring a stockholder vote, and other stockholders may not have the ability to influence corporate transactions.
  • We are highly dependent on our management team, and the loss of our senior executive officers or other key employees could harm our ability to implement our strategies, impair our relationships with customers and adversely affect our business, results of operations and growth prospects.
  • Cyber incidents or attacks directed at us could result in information theft, data corruption, operational disruption and/or financial loss.
  • Our existing indebtedness may adversely affect our ability to obtain additional funds and may increase our vulnerability to economic or business downturns.
  • We may need to raise additional capital in the future, and our failure to do so could restrict our operations or adversely affect our ability to operate and continue our business. There is no guarantee that we will successfully raise additional capital on favorable terms or at all and if and when we need it.
  • Legal and Regulatory Risks
  • Our products are subject to government regulation, both in the United States and abroad, which could increase our costs significantly and limit or prevent the sale of our products.
  • Congress and/or regulatory agencies may impose additional laws or regulations or change current laws or regulations, and state attorneys general may increase enforcement of existing or new laws, and compliance with new or changed governmental regulations, or any state attorney proceeding, could increase our costs significantly and materially and adversely affect our business, financial condition, results of operations and cash flows.
  • Our failure to comply with regulations could result in substantial monetary penalties and could adversely affect our operating results.
  • We may experience product liability claims and litigation to prosecute such claims, and although we maintain product liability insurance, which we believe to be adequate for our needs, there can be no assurance that our insurance coverage will be adequate or that we will be able to obtain adequate insurance coverage in the future. In addition, we may be subject to consumer fraud claims, including consumer class action claims regarding product labeling and advertising, and litigation to prosecute such claims; these claims are generally not covered by insurance.
  • We may experience Lanham Act claims by competitors, and litigation to prosecute such claims.
  • If we fail to protect the integrity and security of customer-related and other confidential information, we could be exposed to litigation, increased costs and reputational damage, and our business, results of operations, cash flows and financial condition could be materially and adversely affected.
  • Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters could significantly affect our financial results.
  • Risks Related to Ownership of Our Common Stock
  • There is a limited trading market for the Company’s common stock; it may be difficult to sell shares.
  • The price of our common stock may be volatile, and you may be unable to resell your shares at or above the price paid.
  • You may be diluted by future issuances of common stock in connection with our incentive plans, acquisitions or otherwise; future sales of such shares in the public market, or the expectations that such sales may occur, could lower our stock price.
  • We do not anticipate paying any cash dividends on our common stock in the foreseeable future.
  • If securities or industry analysts do not publish research or reports about our business, or if they downgrade their recommendations regarding our common stock, its trading price and volume could decline.
  • The requirements of being a public company may strain our resources, divert management’s attention and affect our ability to attract and retain executive management and qualified board members.
  • We may be subject to additional regulatory burdens resulting from our recent public listing.
  • The existence of indemnification rights held by our directors, officers and employees may result in substantial expenses.
  • Anti-takeover effects of certain provisions of Nevada state law hinder a potential takeover of us.
  • We may experience fluctuations in our tax obligations and effective tax rate, which could materially and adversely affect our results of operations.

Legal proceedings

From time to time, we are involved in various litigation matters arising in the ordinary course of our business. We do not believe that any of these matters, individually or in the aggregate, are currently material to us. See the sections titled Business – Legal Proceedings and Note 13 – Commitments and Contingencies – Litigation of the Notes to the Consolidated Financial Statements contained in this Annual Report for information about certain legal proceedings.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
    SEC EDGAROther events
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
    SEC EDGAROther events
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43